{{Rsnum
|rsid=922107
|Gene=LRRC8B
|Chromosome=1
|position=89557237
|Orientation=minus
|GMAF=0.4197
|Gene_s=LRRC8B
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 23.9 | 47.8 | 28.3
| HCB | 6.6 | 32.1 | 61.3
| JPT | 6.2 | 41.6 | 52.2
| YRI | 19.0 | 51.0 | 29.9
| ASW | 21.1 | 40.4 | 38.6
| CHB | 6.6 | 32.1 | 61.3
| CHD | 3.7 | 29.4 | 67.0
| GIH | 33.7 | 48.5 | 17.8
| LWK | 24.5 | 42.7 | 32.7
| MEX | 29.3 | 48.3 | 22.4
| MKK | 17.3 | 46.8 | 35.9
| TSI | 26.5 | 49.0 | 24.5
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=G
  |Pval=3E-6
  |OR=1.79
  |ORtxt=[1.25-2.558]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}